# Verrica Pharmaceuticals Inc.: Form SCHEDULE 13D, filed Nov 24, 2025

- Company: [Verrica Pharmaceuticals Inc.](/companies/vrca.md) (CIK 1660334)
- Form: SCHEDULE 13D
- Filed: 2025-11-24
- Accepted by EDGAR: Nov 24, 2025, 16:15 ET
- Period: not reported
- Accession: 0000902664-25-005145
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1660334/000090266425005145/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1660334/000090266425005145/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1660334/000090266425005145/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 24, 2025.
Source: SEC EDGAR, the filing index for accession 0000902664-25-005145. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.